TY - JOUR ID - 10442/3116 A1 - Kiaris, H. A1 - A1 - Eliopoulos, A. G. A1 - A1 - Sivridis, E. A1 - A1 - Ergazaki, M. A1 - A1 - Spandidos, D. A. Y1 - 1995/// T1 - Activating mutations of ras family genes in prostatic cancer JF - Oncology Reports VL - 2 IS - 3 SN - 1021-335X PB - Demetrios A. Spandidos Ed. & Pub. SP - 427–430EP - UR - https://hdl.handle.net/10442/3116 N2 - ras family genes (H-, K- and N-ras) encode for a 21 kD membrane protein which possesses GTPase activity and participates in a signal transduction pathway. Activating mutations of the ras family genes occur at codons 12, 13 and 61 and have been detected in a variety of human tumours, including colonic, bladder and pancreatic cancers. Prostatic cancer is among the most common malignancies throughout the world and a major cause of death from cancer in males. Data reported on the implication of the ras family genes in the development of the disease are conflicting. The aim of this study was to determine the incidence of mutations at codon 12 of Η-ras, codon 12 of K-ras and codon 61 of N-ras proto-oncogenes, in a Greek population with prostatic cancer. Our analysis revealed that 4 out of 20 (20%) samples harboured a K-ras codon 12 point mutation, 1 out of 20 (5%) specimens contained mutations at codon 12 of the Η-ras and 1 out of 20 (5%) at codon 61 of the N-ras, indicating a role for the ras genes in the development of the disease. ER -